Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 129

1.

Duodenal Rare Neuroendocrine Tumor: Clinicopathological Characteristics of Patients with Gangliocytic Paraganglioma.

Okubo Y, Yokose T, Motohashi O, Miyagi Y, Yoshioka E, Suzuki M, Washimi K, Kawachi K, Nito M, Nemoto T, Shibuya K, Kameda Y.

Gastroenterol Res Pract. 2016;2016:5257312. doi: 10.1155/2016/5257312. Review.

2.

Unusual Cancers of Childhood Treatment (PDQ®): Patient Version.

PDQ Pediatric Treatment Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2017 Jan 4.

3.

Unusual Cancers of Childhood Treatment (PDQ®): Health Professional Version.

PDQ Pediatric Treatment Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2016 Dec 23.

4.

Targeted Molecular Imaging in Adrenal Disease-An Emerging Role for Metomidate PET-CT.

Mendichovszky IA, Powlson AS, Manavaki R, Aigbirhio FI, Cheow H, Buscombe JR, Gurnell M, Gilbert FJ.

Diagnostics (Basel). 2016 Nov 18;6(4). pii: E42. Review.

5.

Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease?

Klaile Y, Schlack K, Boegemann M, Steinestel J, Schrader AJ, Krabbe LM.

Transl Androl Urol. 2016 Oct;5(5):692-701. Review.

6.

Pheochromocytoma and Paraganglioma Treatment (PDQ®): Patient Version.

PDQ Adult Treatment Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2016 Jul 19.

7.

Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects.

Kuroda N, Yorita K, Nagasaki M, Harada Y, Ohe C, Jeruc J, Raspollini MR, Michal M, Hes O, Amin MB.

Pol J Pathol. 2016 Mar;67(1):3-7. Review.

8.

Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer.

Wigerup C, Påhlman S, Bexell D.

Pharmacol Ther. 2016 Aug;164:152-69. doi: 10.1016/j.pharmthera.2016.04.009. Review.

9.

MANAGEMENT OF ENDOCRINE DISEASE: Recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis.

Amar L, Lussey-Lepoutre C, Lenders JW, Djadi-Prat J, Plouin PF, Steichen O.

Eur J Endocrinol. 2016 Oct;175(4):R135-45. doi: 10.1530/EJE-16-0189. Review.

10.

European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma.

Plouin PF, Amar L, Dekkers OM, Fassnacht M, Gimenez-Roqueplo AP, Lenders JW, Lussey-Lepoutre C, Steichen O; Guideline Working Group..

Eur J Endocrinol. 2016 May;174(5):G1-G10. doi: 10.1530/EJE-16-0033. Review.

11.

Heritable Cancer Syndromes Related to the Hypoxia Pathway.

Henegan JC Jr, Gomez CR.

Front Oncol. 2016 Mar 22;6:68. doi: 10.3389/fonc.2016.00068. Review.

12.

Space occupying lesion (paraganglioma) of the urinary bladder in a young male: A case report and brief review of the literature.

Patnayak R, Preetam P, Jena A; Satyanarayana., Subramanian S, Lakshmi AY.

J Cancer Res Ther. 2015 Oct-Dec;11(4):1039. doi: 10.4103/0973-1482.147386. Review.

13.

Yolk sac tumor of the external auditory canal: a case report and literature review.

Shi H, Tang Q, Zhen T, Li H, Zhang F, Han A.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):15001-6. Review.

14.

Primary pancreatic paraganglioma: a case report and literature review.

Lin S, Peng L, Huang S, Li Y, Xiao W.

World J Surg Oncol. 2016 Jan 22;14(1):19. doi: 10.1186/s12957-016-0771-2. Review.

15.

Acute and Chronic Pheochromocytoma-Induced Cardiomyopathies: Different Prognoses?: A Systematic Analytical Review.

Batisse-Lignier M, Pereira B, Motreff P, Pierrard R, Burnot C, Vorilhon C, Maqdasy S, Roche B, Desbiez F, Clerfond G, Citron B, Lusson JR, Tauveron I, Eschalier R.

Medicine (Baltimore). 2015 Dec;94(50):e2198. doi: 10.1097/MD.0000000000002198. Review.

16.

Pheochromocytoma multisystem crisis treated with emergency surgery: a case report and literature review.

Kakoki K, Miyata Y, Shida Y, Hakariya T, Takehara K, Izumida S, Sekino M, Kinoshita N, Igawa T, Fukuoka J, Sakai H.

BMC Res Notes. 2015 Dec 9;8:758. doi: 10.1186/s13104-015-1738-z. Review.

17.

Duodenal gangliocytic paraganglioma: report of two cases and review of literature.

Wang B, Zou Y, Zhang H, Xu L, Jiang X, Sun K.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):9752-9. Review.

18.

[Retroperitoneal paraganglioma: report of a case and literature review].

Fahmi Y, Elabbasi T, Khaiz D, Bensardi FZ, Hattabi K, Berrada S, Lefriyekh R, Fadil A, Zerouali N.

Pan Afr Med J. 2015 Aug 25;21:298. doi: 10.11604/pamj.2015.21.298.6564. Review. French. No abstract available.

19.

Pheochromocytoma and Paraganglioma Treatment (PDQ®): Health Professional Version.

PDQ Adult Treatment Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2015 Jul 10.

20.

MANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytoma.

Castinetti F, Taieb D, Henry JF, Walz M, Guerin C, Brue T, Conte-Devolx B, Neumann HP, Sebag F.

Eur J Endocrinol. 2016 Jan;174(1):R9-18. doi: 10.1530/EJE-15-0549. Review.

Items per page

Supplemental Content

Loading ...
Support Center